Necrostatin 2 (also known as Necrostatin-2, Necrostatin-2 racemate, (±)-Necrostatin-2, 7-Cl-O-Nec-1 and Nec-1s) is a powerful necroptosis inhibitor with an EC50 of 50 nM. It is a racemic mixture that prevents the autophosphorylation of the receptor-interacting protein kinase 1 (RIPK1). A controlled caspase-independent cell death mechanism called necroptosis produces morphological characteristics that resemble necrosis. It can be brought on by TNF-alpha-treated human Jurkat T cells with a FADD-deficient variant. Additionally effective in an animal model of ischemic stroke, necrostatin 2 was. After being administered intravenously, necrostatin 2 showed moderate pharmacokinetic properties and quickly entered the central nervous system.
Physicochemical Properties
Molecular Formula | C13H12CLN3O2 | |
Molecular Weight | 277.71 | |
Exact Mass | 277.062 | |
Elemental Analysis | C, 56.23; H, 4.36; Cl, 12.77; N, 15.13; O, 11.52 | |
CAS # | 852391-19-6 | |
Related CAS # | Necrostatin 2 racemate;852391-15-2;Necrostatin 2 S enantiomer;852391-20-9 | |
PubChem CID | 11288934 | |
Appearance | White to light yellow solid powder | |
LogP | 1.491 | |
Hydrogen Bond Donor Count | 2 | |
Hydrogen Bond Acceptor Count | 2 | |
Rotatable Bond Count | 2 | |
Heavy Atom Count | 19 | |
Complexity | 403 | |
Defined Atom Stereocenter Count | 1 | |
SMILES | C([C@H]1NC(=O)N(C)C1=O)C1=CNC2C(=CC=CC1=2)Cl |
|
InChi Key | WIKGAEMMNQTUGL-SNVBAGLBSA-N | |
InChi Code | InChI=1S/C13H12ClN3O2/c1-17-12(18)10(16-13(17)19)5-7-6-15-11-8(7)3-2-4-9(11)14/h2-4,6,10,15H,5H2,1H3,(H,16,19)/t10-/m1/s1 | |
Chemical Name | (5R)-5-[(7-chloro-1H-indol-3-yl)methyl]-3-methylimidazolidine-2,4-dione | |
Synonyms |
|
|
HS Tariff Code | 2934.99.9001 | |
Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
|
Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
Targets | Necroptosis; RIPK1 | ||
ln Vitro | Nec-1s is a potent inhibitor of RIPK1 and cellular necroptosis while lacking IDO inhibitory activity[1]. | ||
ln Vivo |
Necrostatin 2 R-isomer(Nec-1s) is effective at minimizing brain injuries. It is a superior inhibitor that can be used in vivo and does not have a paradoxical sensitizing effect in TNF-induced lethality[1]. Necrostatin 2 R-isomer(Nec-1s) differs from Nec-1 in that it has a number of favorable pharmacokinetic and pharmacodynamic properties. Because of their lower in vivo and in vitro toxicity, Nec-1s have a safer safety profile than Nec-1[2]. |
||
Enzyme Assay | Necrostatin 2 (also known as Necrostatin-2, Necrostatin-2 racemate, (±)-Necrostatin-2, 7-Cl-O-Nec-1 and Nec-1s, is a potent necroptosis inhibitor with EC50 of 50 nM. | ||
Cell Assay | Cells were treated with indicated concentrations of drug. | ||
Animal Protocol |
|
||
References |
[1]. Cell Death Dis . 2012 Nov 29;3(11):e437. [2]. Molecules . 2018 Aug 3;23(8):1946. [3]. Cell Rep . 2022 Oct 4;41(1):111434. |
Solubility Data
Solubility (In Vitro) |
|
|||
Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (9.00 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.5 mg/mL (9.00 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 3: ≥ 2.5 mg/mL (9.00 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
1 mM | 3.6009 mL | 18.0044 mL | 36.0088 mL | |
5 mM | 0.7202 mL | 3.6009 mL | 7.2018 mL | |
10 mM | 0.3601 mL | 1.8004 mL | 3.6009 mL |